JT
PLSE icon

Jupiter Topco’s Pulse Biosciences PLSE Stock Holding History

Jupiter Topco’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Buy
+8,700
New +$205K ﹤0.01% 2366

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jupiter Topco's PLSE Position: Q2 2026 in Review

Jupiter Topco opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 8,700 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #2366 among its holdings.

99 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Jupiter Topco held 8,700 shares of Pulse Biosciences worth $241K as of Q2 2026.
  • Pulse Biosciences was a new Jupiter Topco position in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2366 holding.
  • 99 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.